OPEN END TURBO LONG - PHARMING GROUP Stock

OPEN END TURBO LONG - PHARMING GROUP Share Price

DE000MG4PZ39

Delayed Börse Stuttgart 02:51:47 27/06/2024 pm IST
0.079 ^EUR	+25.40%

Current month	-32.98%
1 month	-54.01%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart PHARMING GROUP N.V.

Chart OPEN END TURBO LONG - PHARMING GROUP

Latest news about PHARMING GROUP N.V.

Pharming N : Jefferies Healthcare Conference Presentation June 5 6, 2024	05/06	PU
Pharming Group to participate in June investor conferences	03/06	GL
Pharming Group Flags Delay in EU Review of Rare Immunodeficiency Drug	31/05	MT
Pharming N : Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union - Form 6-K	31/05	PU

More news

Quotes 5-day view

Date	Price	Change
27/24/27	0.079	+25.40%
26/24/26	0.063	-25.88%
25/24/25	0.085	-2.30%
24/24/24	0.087	+64.15%
21/24/21	0.053	-5.36%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 02:51 pm IST

More quotes

Static data

Product type	Knock-Out ohne Stop Loss
Buy / Sell	CALL
Underlying	PHARMING GROUP N.V.
Issuer	Morgan Stanley
WKN	MG4PZ3
ISIN	DE000MG4PZ39
Date issued	23/05/2024
Strike	0.7052 €
Maturity	Unlimited
Parity	1 : 1
Emission price	0.11 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	0.152 €
Lowest since issue	0.046 €

Company Profile

Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The Group is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming Group N.V. serves patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia/Pacific.

Sector

More about the company

Ratings for Pharming Group N.V.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Pharming Group N.V.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.7575 EUR

Average target price

1.875 EUR

Spread / Average Target

+147.52%

Consensus